This invention pertains to certain carbamic acid compounds which inhibit HDAC (histone deacetylase) activity of the following formula:
The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HDAC, and in the treatment of conditions mediated by HDAC, cancer, proliferative conditions, psoriasis, etc.
本发明涉及以下公式的抑制H
DAC(组蛋白
去乙酰化酶)活性的某些碳酰胺化合物:本发明还涉及包含这样的化合物的制药组合物,以及在体外和体内使用这样的化合物和组合物来抑制H
DAC,并用于治疗由H
DAC介导的疾病,如癌症,增殖性疾病,牛皮癣等。